It’s a momentous week in Georgia, Washington and these United States. In this special episode of the HealthBiz podcast, Bloomberg Intelligence Analyst, Brian Rye and I discuss the health policy implications of the likely 50+1 Democratic Senate majority. Listen as we discuss drug pricing, Medicare Advantage, and the public option.

As of March 2025 HealthBiz is part of CareTalk. Healthcare. Unfiltered and can be found at the following links:

Spotify https://open.spotify.com/show/2GTYhbNnvDHriDp7Xo9s6Z
Apple https://podcasts.apple.com/us/podcast/caretalk-healthcare-unfiltered/id1532402352
YouTube https://www.youtube.com/@CareTalkPodcast
CareTalk website https://www.caretalkpodcast.com/

Host David E. Williams is president of healthcare strategy consulting firm Health Business Group.

Episodes through March 2025 were produced by Dafna Williams.

What’s next for healthcare as Dems take the Senate?